… Tumor necrosis factor (TNF) is a pleotropic cytokine involved in a wide range of pathological
processes, including inflammatory bowel disease (IBD). In the past, TNF was recognized as …

… (anti-TNF) antagonists have been the mainstay in the treatment of inflammatory bowel
diseases (… Summary: This review article aimed to provide an update on recent advances in TNF …

… (Crohn’s disease OR inflammatory bowel disease OR ulcerative … (tumor necrosis factor OR
tumor necrosis factor-alpha OR TNF) AND (Crohn’s disease OR inflammatory bowel disease …

… of disease remission in most patients[24,30]. This review aims to provide the main aspects
of IBD and TNF-α relationship, elucidating the role of the TNF-α receptors, anti TNF-α therapy …

… Anti-tumor necrosis factor α (anti-TNFα) drugs have been increasingly used for the treatment
of IBD ( 5 ). Therefore, many women wishing to become pregnant may be exposed to these …

… Anti-tumor necrosis factor α (anti-TNF-α) is important in the treatment of inflammatory bowel
disease, … In these patients, a combination of anti-TNF-α and vedolizumab (VDZ) may act as a …

… α (anti-TNFα) agents are widely used as maintenance treatment for patients with inflammatory
bowel disease … of a subsequent loss of response to anti-TNFα has been estimated to be as …

… It is not clear what serum levels of anti–tumor necrosis factor are associated with reduced
intestinal inflammation in patients with inflammatory bowel disease (IBD). We aimed to identify …

… necrosis factor α (anti-TNF-α) antibodies in the therapy of inflammatory bowel disease (IBD)
are not completely understood. Binding of antibodies to transmembrane TNF-α seems to be …

… Anti-tumor necrosis factor-α (TNF-α) is used for the treatment of severe cases of IBD, including
Crohn's disease (CD) and ulcerative colitis (UC). However, one-third of the patients do not …